Karius is a life science startup that specializes in transforming the diagnosis of infectious diseases through advanced genomic technologies. By harnessing Next-Generation Sequencing and proprietary data analysis, Karius can identify over 1,000 pathogens from a single blood sample, typically delivering results within a day. Their mission is to empower healthcare professionals with comprehensive insights derived from microbial cell-free DNA, enabling them to tackle complex diagnostic challenges and improve patient outcomes. Karius is committed to innovation and collaboration, continuously striving to enhance clinical trials and discovery efforts that ultimately aim to reduce patient suffering worldwide. The company emphasizes teamwork, diversity, and a commitment to excellence, ensuring that every member contributes to creating life-changing solutions in infectious disease diagnostics.